Search Results 1021-1030 of 18559 for hepatitis

1. A Study of Donor-Alloantigen-Reactive Regulatory T Cell Therapy with an Immunosuppression Regimen in Adult Liver Transplantation - Mayo Clinic

   End stage liver disease secondary to autoimmune etiology (autoimmune hepatitis, primary biliary cirrhosis, or primary sclerosing cholangitis). History of ...

2. Videos - Membrane Trafficking in Disease - Mayo Clinic Research

   ... Hepatitis B Infection · Tumor Cell Growth and Migration · Publications; Media Media. Images · Videos · Contact. Videos. All videos are copyrighted by Mayo ...

3. A Study to Evaluate the Safety and Effectiveness of IFX-1 in Add-on to Standard of Care in Patients with Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA) - Mayo Clinic

   ... hepatitis B, or hepatitis C. One of the following abnormal laboratory findings at Screening: White blood cells < 3500/mm3; Platelet count < 120,000/mm3; Total ...

4. Pediatric metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as nonalcoholic fatty liver disease (NAFLD) - Mayo Clinic

   ... hepatitis. Other tools that may be useful in diagnosis include ultrasound, liver biopsy and magnetic resonance imaging with magnetic resonance elastography ...

5. Pembrolizumab in Treating Patients With Small Bowel Adenocarcinoma That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery - Mayo Clinic

   Known active hepatitis B (e.g., hepatitis B surface antigen [HBsAg] reactive) or hepatitis C (e.g., hepatitis C virus [HCV] ribonucleic acid RNA [qualitative] ...

6. Primary Cell Lines Derived from the Human Gall Bladder for the Purpose of Gene and Cell Therapy for Metabolic Liver Disorders - Mayo Clinic

   No gallbladders will be collected from patients with known infection with either HIV or Hepatitis C. Participating Mayo Clinic locations. Study statuses ...

7. Clinical Trials - Belimumab in Remission of VASculitis

   Current or past positive test for human immunodeficiency virus (HIV), hepatitis B, or hepatitis C. History of severe allergic reaction to contrast agents or ...

8. Mayo Clinic Minute: Saving more lives by expanding the donor pool

   Something else that's helping to expand donor pools is the new generation of antivirals that allow for the safe transplantation of organs from hepatitis C- ...

9. A Study to Evaluate Pembrolizumab and Dasatinib, Imatinib Mesylate, or Nilotinib in Treating Patients with Chronic Myeloid Leukemia and Persistently- Detectable Minimal Residual Disease - Mayo Clinic

   Patients must not have a known history of Hepatitis B (defined as Hepatitis B surface antigen [HBsAg] reactive). Patient must not have received a live ...

10. Publications - Liu Yang, M.B.B.S. - Mayo Clinic

    ... Hepatitis. Hepatology. 2020 Aug; 72 (2):441-453 Epub 2020 Apr 27. View PubMed; Croome KP, Mao S, Yang L, Pungpapong S, Wadei HM, Taner CB. Improved National ...